Who owns the COUMADIN (WARFARIN SODIUM TABLETS, USP) trademark?

The COUMADIN (WARFARIN SODIUM TABLETS, USP) trademark is owned by Bristol-Myers Squibb Pharma Company.

What class is the COUMADIN (WARFARIN SODIUM TABLETS, USP) trademark registered in?

The COUMADIN (WARFARIN SODIUM TABLETS, USP) trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for COUMADIN (WARFARIN SODIUM TABLETS, USP)?

The USPTO serial number for COUMADIN (WARFARIN SODIUM TABLETS, USP) is 87226817.

What is the registration number for COUMADIN (WARFARIN SODIUM TABLETS, USP)?

COUMADIN (WARFARIN SODIUM TABLETS, USP) is registered under USPTO registration number 5222641.

COU

USPTO Trademark Record

ABANDONED

COUMADIN (WARFARIN SODIUM TABLETS, USP)

SN 87226817·Reg 5222641·Filed Nov 04, 2016

Owner Bristol-Myers Squibb Pharma Company

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

COUMADIN (WARFARIN SODIUM TABLETS, USP) (Serial No. 87226817), Registration No. 5222641, is a abandoned US trademark filed on Nov 04, 2016 by Bristol-Myers Squibb Pharma Company. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Mark Intelligence

COUMADIN (WARFARIN SODIUM TABLETS, USP) (Reg. #5222641) is an abandoned US trademark that was filed in 2016 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Nov 04, 2016

SERIAL

87226817

REG#

5222641

REGISTERED

Jun 13, 2017

Owner

Applicant

Bristol-Myers Squibb Pharma Company

Entity

Corporation

State

Address

Route 206 & Province Line Road, Princeton, NJ, 08540

Country

Attorney

NameMarilyn F. Kelly

Law firm

MARILYN F. KELLY BRISTOL-MYERS SQUIBB COMPANY

Address

P.O. BOX 4000, TRADEMARKS DEPT., MAILSTOP D33-05, PRINCETON, NJ 08648-4000, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateNov 04, 2016

Serial Number87226817

Registration No.5222641

Registration DateJun 13, 2017

Status DateDec 29, 2023

Published for OppositionMar 28, 2017

Mark TypeDesign with words

Status DescriptionDead and cancelled, Section 8

Filing Signals

FILED

2016

YEARS AGO

10y

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

First use anywhere: Apr 12, 2002

First use in commerce: Apr 12, 2002

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

11 events

CANCELLED SEC. 8 (6-YR)

Dec 29, 2023

CANCELLED SEC. 8 (6-YR)

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Jun 13, 2022

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

REGISTERED-PRINCIPAL REGISTER

Jun 13, 2017

REGISTERED-PRINCIPAL REGISTER

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Mar 28, 2017

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

PUBLISHED FOR OPPOSITION

Mar 28, 2017

PUBLISHED FOR OPPOSITION

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 08, 2017

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Feb 16, 2017

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Feb 12, 2017

ASSIGNED TO EXAMINER

NOTICE OF DESIGN SEARCH CODE E-MAILED

Nov 09, 2016

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION ENTERED

Nov 08, 2016

NEW APPLICATION ENTERED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Nov 08, 2016

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

COUMADIN (WARFARIN SODIUM TABLETS, USP)

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Bristol-Myers Squibb Pharma Company

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Marilyn F. Kelly

Resources

Company